Among the many SPC drugs, the combination of calcium channel blockers and renin‐angiotensin system inhibitors (RASI), either angiotensin‐converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs), has been shown to be effective and safe in the treatment of patients with hypertension.57, 58. This evidence concerns the gene REN and hypertensive disorder.